Learn About Monoclonal Antibodies in Cancer Treatment

Monoclonal antibodies are an important type of targeted cancer treatment. These medicines are designed to recognize specific molecules, often called antigens, that may be present on cancer cells or other cells involved in cancer growth. Unlike treatments that affect many rapidly dividing cells, monoclonal antibodies are developed to interact with particular biological targets. Their role in cancer care depends on the type of cancer, the characteristics of the tumor, and the specific antibody being used. Some are also combined with chemotherapy, radiation therapy, or other forms of cancer treatment.

How Monoclonal Antibodies Work in Cancer Treatment

Monoclonal antibodies can work through several mechanisms. Some attach directly to proteins on cancer cells and interfere with signals that support cell growth or survival. Others help the immune system recognize and respond to cancer cells. Certain antibodies are also designed to carry another substance, such as a chemotherapy drug or radioactive material, toward cells with a specific target.

• Blocking growth signals: Some antibodies interfere with proteins or receptors that can contribute to cancer cell growth.
• Supporting immune responses: Certain monoclonal antibodies may help the immune system recognize cancer cells more effectively.
• Targeting blood vessel growth: Some treatments block signals involved in the formation of blood vessels that can supply nutrients to tumors.
• Delivering treatment to specific cells: Antibody drug conjugates can combine an antibody with a treatment substance that is carried toward cells expressing a particular target.
• Marking cancer cells: When an antibody attaches to a cancer cell, it may make that cell easier for parts of the immune system to identify.

The availability of a monoclonal antibody treatment often depends on whether the cancer cells contain the specific target for which the medicine was developed. Healthcare professionals may use laboratory or biomarker testing to determine whether a particular treatment is appropriate.

Types Uses and Possible Side Effects of Monoclonal Antibodies

Monoclonal antibodies are used in the treatment of several cancers, including certain blood cancers, breast cancers, lung cancers, colorectal cancers, and other malignancies. Each medicine has a specific purpose and is approved or used according to the characteristics of the disease and the treatment setting.

Treatment may be administered through an intravenous infusion, while some medicines may be given by injection under the skin. The treatment schedule can vary depending on the medicine and the overall care plan.

Possible side effects also differ among monoclonal antibodies and may depend on how the medicine works. Some reactions can occur during or after administration, while others are related to the specific biological pathway being targeted.

• Infusion or injection reactions: Fever, chills, rash, or breathing-related symptoms may occur in some individuals.
• Fatigue and general weakness: These effects can occur during cancer treatment for different reasons.
• Skin changes: Some targeted therapies may cause rashes or other skin-related effects.
• Digestive symptoms: Nausea, diarrhea, or other digestive changes may occur with certain treatments.
• Immune-related or organ-specific effects: Depending on the type of antibody, some medicines can affect normal tissues or biological processes.

Monoclonal antibody therapy is selected based on individual medical factors, including the type and stage of cancer, biomarker results, previous treatments, and overall health. Patients can discuss the expected benefits, treatment process, monitoring requirements, and potential side effects with their oncology team. This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.